PTCH1 and neoplasm: In summary, these data demonstrate that in vivo treatment of Ptch mutant ERMS with SMO inhibitors and/or pictilisib either stop or reduce tumor growth and that sonidegib monotherapy or a HhAntag/pictilisib combination therapy show the strongest antitumor effects.